New CBD Regulatory Framework Published by France’s Ministry of Health Opens New Commercial Opportunities for RAMM Pharma’s European Operations

Linda Rider

TORONTO, Jan. 05, 2022 (Globe NEWSWIRE) — RAMM Pharma Corp., which includes its wholly owned subsidiaries, the “Enterprise” or “RAMM”) (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical solutions, applauds France’s new regulatory framework for the sale of cannabidiol (“CBD”). Pursuant to the recent announcement, France will enable the utilization […]

Subscribe US Now